NBNandhini Balunathan

Nandhini Balunathan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nandhini Balunathan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic variants involved in sperm motility and their association with sperm motility parameters and risk of male infertility: a systematic review and meta-analysis protocol

    by Abna Ajeesh, Nandhini Balunathan

    Introduction About 40–50% of cases of infertility globally are caused by male infertility. Asthenozoospermia, or decreased sperm motility, is one of the most prevalent causes of male infertility. Because sperm cells must pass through the female reproductive canal and enter the oocyte, sperm motility is necessary for successful fertilisation. Male infertility may be significantly influenced by genetic variations in genes controlling sperm motility, according to mounting research. Sperm motility has been linked to a number of genes, including those in the CATSPER family, cilia and flagella-associated proteins, A-kinase anchoring proteins and hormonal regulatory genes, including FSHR, FSHB and LHB. Individual study results, however, continue to be contradictory. The purpose of this systematic review and meta-analysis is to assess the relationship between the risk of male infertility and genetic variations related to sperm motility and sperm motility parameters. Methods and analysis To find pertinent research published between January 2021 and February 2026, a thorough literature search will be carried out in PubMed, Scopus and Embase. We will only consider case-control studies that have been published in English. The Newcastle-Ottawa Scale will be used by two independent reviewers to identify papers, collect data and evaluate methodological quality. A meta-analysis will be carried out to determine pooled effect sizes where there is enough data, and a narrative synthesis will be used to summarise research characteristics. To ascertain whether genetic variations and male infertility are related, ORs with 95% CIs will be computed. Ethics and dissemination Since this study will use data from previously published studies, ethical approval is not necessary. The findings will be presented at scientific conferences and published in peer-reviewed journals. PROSPERO registration CRD420261291792.

  • The Emerging Role of CFAP Family Genes in Male Infertility

    by Malavika Manikanda, Ernest Relin Fernando Reynold, Abna Ajeesh, Nandhini Balunathan

  • Open Access

    Chromosomal abnormalities and hypodiploidy in the chronic phase of paediatric chronic myelogenous leukaemia

    by Vijayalakshmi Jagannathan, Gokull Perumalsamy, Dhaarani Jayaraman, Nandhini Balunathan, Julius Xavier Scott

  • Gene-Polymorphism in Non - Syndromic Hearing Loss: A Systematic Review

    by Nandhini Balunathan, Shital S. Nair, Simon Roshan Kumar

    Hearing loss that happens alone, without other related physical or developmental issues, is known as non-syndromic hearing loss (NSHL). About 70% of instances of hereditary hearing impairment are of this kind, making it the most prevalent type of genetic hearing loss. There are three possible inheritance patterns for the condition: autosomal dominant, autosomal recessive, and X-linked. The most common type is autosomal recessive. Studies have shown a large number of genes implicated in the auditory system, and genetic variables are important in the development of NSHL. These comprise genes encoding elements of the central auditory circuits, auditory nerve, and cochlea. Hearing loss can result from a number of mutations or polymorphisms (differences in the DNA sequence) in various genes, ranging from mild to profound. Thus several studies showing different gene involved, a systematic review is needed. Two databases PubMed (medicine) and Google scholar, as the main literature source and performed literature searches using relatively mature search formula. Based on the inclusion and exclusion criteria, after screening 150 articles, 12 articles were selected and reviewd for the study. The results demonstrate that NSHL is largely caused by genetic alterations, with some polymorphisms being more common in particular populations. For instance, GJB2-related mutations are uncommon in sub-Saharan Africa, where other genetic variables probably prevail, but they are noticeably widespread in Asian and Caucasian populations.


  • Single nucleotide polymorphisms of Interleukin − 4, Interleukin-18, FCRL3 and sPLA2IIa genes and their association in pathogenesis of endometriosis

    by Nandhini Balunathan, Usha Rani G, Venkatachalam Perumal, P. Kumarasamy

    Background Endometriosis is a complex gynaecological disorder that contributes to infertility, dysmenorrhea, dyspareunia, and other chronic issues. It is a multifactorial disease involving genetic, hormonal, immunological and environmental components. Endometriosis’s pathogenesis remains unclear. Aim of the study was to analyse the polymorphisms in Interleukin 4, Interleukin 18, FCRL3 and sPLA2IIa genes to identify any significant association with the risk of endometriosis. Material and methods This study evaluated the polymorphism of -590 C/T in interleukin- 4(IL-4) gene, C607A in Interleukin − 18(IL-18) gene, -169T > C in FCRL3 gene and 763 C > G in sPLA2IIa gene in women with endometriosis. The case-control study included 150 women with endometriosis and 150 apparently healthy women as control subjects. DNA was extracted from peripheral blood leukocytes and endometriotic tissue of cases and blood samples for controls and further analysed by PCR amplification and then sequencing was carried out to find the allele and genotypes of the subjects and then to analyse the relationship between the gene polymorphisms and endometriosis. To evaluate the association of the different genotypes, 95% confidence intervals (CI) were calculated. Results Interleukin − 18 and FCRL3 gene polymorphisms of endometriotic tissue and blood samples of endometriosis (cases) showed significantly associated (OR = 4.88 [95% CI = 2.31–10.30], P > 0.0001) and (OR = 4.00 [95% CI = 2.2–7.33], P > 0.0001) when compared with normal blood samples. However, there was no significant difference in Interleukin − 4 and sPLA2IIa gene polymorphisms between control women and patients with endometriosis. Conclusions The present study suggests that the IL-18 and FCRL3 gene polymorphisms are associated with a higher risk for endometriosis, which delivers valuable knowledge of endometriosis’s pathogenesis. However, a larger sample size of patients from various ethnic backgrounds is necessary to evaluate whether these alleles have a direct effect on disease susceptibility.


  • Ring chromosome 8 and trisomy 8 in a patient with acute myeloid leukemia

    by Bibhas Kar, B. Nandhini, R. Revathi

    We describe a child with Acute Myeloid Leukemia (AML M7) with trisomy 8 and ring chromosome 8. Ring chromosome 8 associated with AML is uncommon and is reported to have a poor outcome. The combination of trisomy 8 and ring chromosome 8 has not been previously reported. This 15-month-old girl had presented with a history of fever, weight loss of 1 kg, gum bleeds and pallor. Clinical examinations revealed no nodes or organomegaly. Investigations revealed pancytopenia and elevated serum LDH. Bone marrow aspirate confirmed the presence of myeloid blasts positive only for CD 41 and CD 61 on flow cytometry. Chromosomal analysis from the bone marrow showed 46, XX [13]/ 47, XX, +8[2]/ 47, XX, +r (8) [5]. The child was treated as per UK MRC AML protocol (ADE 10+3+5). Bone marrow on day 21 post-induction was in morphological remission. Repeat karyotyping revealed 46,XX suggesting that the patient was in cytogenetic remission. Cytogenetic sub grouping in AML patients provides guidelines for the choice of optimal treatment strategy. There was no HLA matched family donor and hence an unrelated donor search was commenced as she was in the group with unfavourable cytogenetics. She developed acute myelofibrosis soon after the second cycle of chemotherapy with swinging fever and rapidly enlarging spleen. The marrow showed 11% blasts with intense fibrosis. She went through a stormy period during conditioning for unrelated stem cell transplantation. She passed away on day 11 post transplantation of veno-occlusive disease of liver and multiorgan failure. This case illustrates the poor outcome in paediatric AML with trisomy and ring chromosome 8.